Order Article Reprints

Altmayer LA, Lang M, Schleicher JT, Stuhlert C, Wörmann C, Scherer L-S, Thul IC, Spenner LS, Simon JA, Wind A, et al. A Plea for Monitoring Serum Selenium Levels in Breast Cancer Patients: Selenium Deficiency Is Rare during the First Year of Therapy, and Selenium Supplementation Is Associated with Elevated Risk of Overdosing. Nutrients. 2024; 16(13):2134. https://doi.org/10.3390/nu16132134

Altmayer, Laura Alicia, Marina Lang, Julia Theresa Schleicher, Caroline Stuhlert, Carolin Wörmann, Laura-Sophie Scherer, Ida Clara Thul, Lisanne Sophie Spenner, Jana Alisa Simon, Alina Wind, and et al. 2024. "A Plea for Monitoring Serum Selenium Levels in Breast Cancer Patients: Selenium Deficiency Is Rare during the First Year of Therapy, and Selenium Supplementation Is Associated with Elevated Risk of Overdosing" Nutrients 16, no. 13: 2134. https://doi.org/10.3390/nu16132134

Altmayer, L. A., Lang, M., Schleicher, J. T., Stuhlert, C., Wörmann, C., Scherer, L.-S., Thul, I. C., Spenner, L. S., Simon, J. A., Wind, A., Tokcan, M., Kaiser, E., Weber, R., Goedicke-Fritz, S., Wagenpfeil, G., Zemlin, M., Solomayer, E.-F., Reichrath, J., Müller, C., & Zemlin, C. (2024). A Plea for Monitoring Serum Selenium Levels in Breast Cancer Patients: Selenium Deficiency Is Rare during the First Year of Therapy, and Selenium Supplementation Is Associated with Elevated Risk of Overdosing. Nutrients, 16(13), 2134. https://doi.org/10.3390/nu16132134